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Zika Virus,  
French Polynesia, 
South Pacific, 2013
To the Editor: We wish to clarify 
an inaccuracy in a letter in Emerging 
Infectious Diseases by Cao-Lormeau 
et al. (1). The authors state “In 2007, 
the first ZIKV outbreak reported out-
side Africa and Asia was retrospec-
tively documented from biological 
samples from patients on Yap Island, 
Federated States of Micronesia, North 
Pacific, who had received an incorrect 
diagnosis of dengue virus (DENV).” 
Although the first outbreak of Zika vi-
rus (ZIKV) infection reported outside 
Africa or Asia was in Yap, it was not 
retrospectively identified from serum 
samples incorrectly diagnosed as posi-
tive for dengue virus. The outbreak 
was first identified by the Yap State 
Department of Health Services, and 
an investigation to determine the etio-
logic agent was initiated.
Although dengue was initially part 
of the differential diagnosis, and a few 
patients had evidence of IgM against 
dengue virus by a rapid diagnostic test, 
clinicians in Yap believed that the clini-
cal syndrome was not consistent with 
dengue. Thus, assistance was request-
ed from the US Centers for Disease 
Control and Prevention and the World 
Health Organization to strengthen the 
epidemiologic investigation and pro-
vide confirmatory laboratory testing.
Serum samples collected during 
the active investigation were sent to the 
Arboviral Diseases Diagnostic Labora-
tory at the Centers for Disease Control 
and Prevention where testing deter-
mined that the cause of the infections 
was ZIKV (2). This discovery of ZIKV 
as the etiologic agent was not achieved 
through retrospective testing of serum 
from patients incorrectly diagnosed as 
having dengue, but rather the result of 
an active, coordinated investigation by 
the Yap State Department of Health 
Services with instrumental assistance 
from international partners.
W. Thane Hancock,  
Maria Marfel, and Martin Bel
Author	affiliation:	Yap	State	Department	of	




  1. Cao-Lormeau VM, Roche C, Teissier A, 
Robin E, Berry AL, Mallet HP, et al. Zika 
virus, French Polynesia, South Pacific, 
2013. Emerg Infect Dis. 2014;20:1085–6. 
http://dx.doi.org/10.3201/eid2006.140138
  2 Duffy MR, Chen TH, Hancock WT, 
Powers AM, Kool JL, Lanciotti RS. 
Zika outbreak on Yap Island, Feder-
ated States of Micronesia. N Engl J 
Med. 2009;360:2536–43. http://dx.doi.
org/10.1056/NEJMoa0805715
Address for correspondence: W. Thane 
Hancock, Yap State Department of Health 
Services, EpiNet, PO Box 148, Colonia, Yap 
96943, Federated States of Micronesia; email: 
thane@fsmhealth.fm
In Response: I want to respond to 
the letter by Hancock et al. (1) regard-
ing the previously published letter, 
Zika Virus, French Polynesia, South 
Pacific, 2013 (2). My comment aims 
to clarify an inaccuracy in the follow-
ing sentence. “In 2007, the first Zika 
outbreak ever reported outside Africa 
and Asia was retrospectively docu-
mented from biological samples of pa-
tients on Yap Island, Federated States 
of Micronesia, North Pacific, who had 
received an incorrect diagnosis of den-
gue virus (DENV)” (2).
I recognize that this sentence does 
not provide an accurate description of 
the efforts in Yap State to investigate 
the outbreak and further confirm that 
it was caused by Zika virus (ZIKV). 
As specified in the article by Lanciot-
ti et al. (3), outbreak investigations 
continued although initial laboratory 
testing suggested dengue virus as the 
causative agent: “In April 2007, an 
epidemic of rash, conjunctivitis, and 
arthralgia was noted by physicians in 
Yap State, Federated States of Micro-
nesia. Laboratory testing with a rapid 
assay suggested that a dengue virus 
(DENV) was the causative agent. 
In June 2007, samples were sent for 
confirmatory testing to the Arbovirus 
Diagnostic Laboratory at the Centers 
for Disease Control and Prevention 
(CDC, Fort Collins, CO, USA).” 
I apologize to the Yap Epinet 
Team for this inaccuracy, and I en-
courage the reader to consult the arti-
cles by Lanciotti et al. (3) and Duffy 
et al. (4) to get a complete descrip-
tion of the clinical and laboratory 
investigations conducted during the 
ZIKV outbreak in Yap State. If data 
and laboratory protocols (reverse 
transcription PCR) related to this 
first ZIKV outbreak in the Pacific had 
not been available to the scientific 
community, identification of ZIKV 
as the cause of an outbreak in French 
Polynesia in 2013 would have been 
greatly delayed.
Van-Mai Cao-Lormeau
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